HB1076
Pharmaceutical Substance Manufacturing Grant Fund; established.
Status:
In House
Latest Action:
Jan. 30, 2026
House: Reported from Appropriations (21-Y 0-N)
Chief Patron:
Amy Laufer (D)
Session:
2026 Regular Session
Summary
As Introduced. Pharmaceutical Substance Manufacturing Grant Fund.
Establishes the Pharmaceutical Substance Manufacturing Grant Fund to provide grant installment awards between July 1, 2026, and July 1, 2045, in an amount not to exceed $34 million per fiscal year and in an aggregate amount not to exceed $191,255,000 million, to a qualified company that (i) engages in the ... (More) manufacture of pharmaceutical substances, (ii) executes a memorandum of understanding with the Commonwealth, and (iii) is expected to make a capital investment of at least $4 billion and create and maintain at least 500 new full-time jobs. (Less)-
Bill History
- 01/14/2026 - House: Prefiled and ordered printed; Offered 01-14-2026 26102903D
- 01/14/2026 - House: Referred to Committee on Appropriations
- 01/22/2026 - House: Assigned HAPP sub: Commerce Agriculture & Natural Resources
- 01/23/2026 - House: Fiscal Impact Statement from Department of Planning and Budget (HB1076)
- 01/27/2026 - House: Placed on Appropriations Agenda
- 01/28/2026 - House: Subcommittee recommends reporting (5-Y 0-N)
- 01/29/2026 - House: Placed on Appropriations Agenda
- 01/30/2026 - House: Reported from Appropriations (21-Y 0-N)
